SMAD4 and hepatocellular carcinoma: Therefore, we suggest that the inhibition of Smad4 and TGF‐β signalling contributes to the DSF/Cu‐induced anti‐metastatic effect and the down‐regulation of EMT in hepatocellular carcinoma cells.